CSIMarket Company Name, Ticker, Competitors, else..
 
Inspira Technologies Oxy B H N Ltd  (NASDAQ: IINN)
 
Price: $1.2600 $1.26 %
Day's High: $1.3200000524520874 Week Perf: -21.74 %
Day's Low: $ 1.24 30 Day Perf: -17.11 %
Volume (M): 2,512,930 52 Wk High: $ 3.85
Volume (M$): $ 0 52 Wk Avg: $0.93
Open: $1.27 52 Wk Low: $0.28



 Market Capitalization (Millions $) 23
 Shares Outstanding (Millions) 19
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 11
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Business Description


Inspira Technologies Oxy B h n Ltd is a company that develops and provides innovative oxygen therapy solutions. They specialize in the manufacturing of oxygen concentrators, portable oxygen cylinders, and related accessories. Their products are designed to help individuals with respiratory conditions effectively manage their oxygen therapy needs. With a focus on quality and reliability, Inspira Technologies aims to improve the overall well-being and quality of life for those who require supplemental oxygen.


   Company Address: 2 Ha-Tidhar St Ra’anana 4366504
   Company Phone Number: 6230333   Stock Exchange / Ticker: NASDAQ IINN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
STIM   -2.04%    
• View Complete Report
   



Clinical Study

Advancements in Non-Invasive Blood Monitoring Inspira Technologies Concludes Clinical Study on HYLA Sensor

Published Thu, Nov 13 2025 2:26 PM UTC

In the rapidly evolving field of medical diagnostics, non-invasive technologies are becoming increasingly significant. They not only enhance patient comfort but also promise quicker and safer evaluation processes. Recently, Inspira Technologies OXY B.H.N. Ltd., announced a significant milestone in the development of its HYLA blood sensor, an innovative step forward in non-in...
Clinical Study

Expanding Horizons The INSPIRA ART100 System’s Role in Enhancing Lung Transplant Outcomes

Published Tue, Sep 2 2025 1:08 PM UTC

The landscape of respiratory care is evolving, particularly within the realm of organ transplantation, where innovative technologies are reshaping treatment paradigms. Inspira Technologies OXY B.H.N. Ltd. has made significant strides in this field with the expansion of its promising INSPIRA ART100 system. Recently, a top U.S. hospital, recognized in the U.S. News & World Rep...
Contract

Inspira Technologies In Government Talks to Boost ART100 Integration and Global Reach

Published Tue, Jul 8 2025 8:48 AM UTC

Inspira Technologies Eyes Strategic Growth through Government Talks and Strong Financial Performance Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN), based in Ra anana, Israel, is making significant moves as it engages in high-level discussions with a major government health authority, aiming to solidify the integration of its ART100 system as a key asset in national eme...
Business Update

Inspira Technologies Transforming ICU Care with AI-Powered Solutions for a $25 Billion Market,

Published Tue, Mar 18 2025 7:09 PM UTC

Revolutionizing Respiratory Care: Inspira Technologies AI-Powered System Set to Transform ICU Treatment for Millions In a groundbreaking development in the healthcare sector, Inspira Technologies (NASDAQ: IINN) is positioned to disrupt the respiratory care market with its innovative, AI-driven respiratory system. The recent PESG Report has detailed the company’s ongoing s...
Business Update

Inspira Technologies Strengthens Blood Monitoring with Groundbreaking AI-Powered Sensor

Published Sat, Mar 8 2025 3:03 PM UTC

In the continuously evolving field of biotechnology, innovation often comes hand in hand with cautious optimism. Inspira Technologies (NASDAQ: IINN) has recently garnered attention for its pioneering advancements in blood monitoring through its AI-powered HYLA blood sensor. The latest update from PESG Research highlights the impressive clinical data released by Inspira Techn...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 10.04
PEG (TTM) -

Financial Strength Current
Quick Ratio 3.44
Working Capital Ratio 4.01
Leverage Ratio (MRQ) 0.8
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.6 $
Revenues (TTM) -
Cash Flow (TTM) 0 $
Cash 0.35 $
Book Value 0.13 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 80.55 %
Return On Investment (TTM) 361.06 %
Return On Equity (TTM) 361.06 %
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.